A splice junction mutation in muscle carnitine palmitoyltransferase II deficiency

Marcus Deschauer, Zofia M.A. Chrzanowska-Lightowlers, Eckhard Biekmann, Morteza Pourfarzam, Robert W. Taylor, Douglass M. Turnbull, Stephan Zierz

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

We report the first splice junction mutation to be described in the carnitine palmitoyltransferase (CPT) 2 gene in a patient with the muscle form of CPT II deficiency. The patient, a 25-year-old man, suffered from attacks of myalgia and muscle weakness in early adult life. There was biochemical evidence of CPT II deficiency. Molecular genetic analysis revealed the common S113L mutation on one allele whilst a novel mutation at the splice donor junction in intron 3 was identified on the other allele. Sequencing of reverse transcription polymerase chain reaction (RT-PCR) products clearly demonstrated that this mutation causes the skipping of exon 3, thus establishing its pathogenic role.

Original languageEnglish
Pages (from-to)124-128
Number of pages5
JournalMolecular Genetics and Metabolism
Volume79
Issue number2
DOIs
StatePublished - 1 Jun 2003
Externally publishedYes

Keywords

  • Carnitine palmitoyltransferase II deficiency
  • Molecular analysis
  • Splice junction mutation

Fingerprint

Dive into the research topics of 'A splice junction mutation in muscle carnitine palmitoyltransferase II deficiency'. Together they form a unique fingerprint.

Cite this